ADVANCED SOLID TUMOURS
Clinical trials for ADVANCED SOLID TUMOURS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOURS trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOURS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental KRAS drug trial halted early – what we know
Disease control TerminatedThis early-stage trial tested a new drug called AZD0022 in 17 people with advanced solid tumors (like lung, pancreatic, or colorectal cancer) that have a specific KRASG12D mutation. The study was stopped early, but researchers were checking if the drug is safe and shrinks tumors …
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 04:28 UTC
-
Radioactive drug trial for advanced cancers halted early
Disease control TerminatedThis study tested a new radioactive drug, [225Ac]-FPI-1434, in people with advanced solid tumors that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was terminated early, so results are limited. It involved 78 partic…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
Cancer drug interaction study ends early after just one volunteer
Knowledge-focused TerminatedThis study aimed to see how a drug called ceralasertib affects the way the body processes three other drugs (Drug X, Y, and Z) in people with advanced solid tumours. Only one person took part before the study was stopped early. The main goal was to measure drug levels in the bloo…
Matched conditions: ADVANCED SOLID TUMOURS
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 17, 2026 04:16 UTC